OLIN Corp OLN

Healthcare SIC 2800 - Chemicals & Allied Products NAICS Manufacturing › Chemical Manufacturing derived NYSE

Last close 15.66 2026-10-23
Market cap $1.78B 2026-06-30 share count
52-week range 14.64 - 30.46

Valuation FY2025 figures against the last close

P/S0.3x
P/E—
P/FCF7.2x
EV/EBITDA8.4x
Dividend yield5.1%
Diluted EPS-0.88

Where the revenue comes from as reported in the latest 10-K

Revenue by geography

  • U.S.
  • Other foreign
  • Europe
Revenue by geography, 3 categories over 3 years. The same figures are in the table below. FY2025 U.S., FY2025: 4.6B (67.6%) 68% U.S. Other foreign, FY2025: 1.5B (22.8%) 23% Other foreign Europe, FY2025: 647.4M (9.5%) 10% Europe FY2024 U.S., FY2024: 4.7B (71.2%) 71% Other foreign, FY2024: 1.3B (19.7%) 20% Europe, FY2024: 592.3M (9.1%) 9% FY2023 U.S., FY2023: 4.6B (67.3%) 67% Other foreign, FY2023: 1.6B (23.9%) 24% Europe, FY2023: 603.7M (8.8%) 9%
Region FY2025FY2024FY2023
U.S. $4.59B $4.66B $4.60B
Other foreign $1.55B $1.29B $1.63B
Europe $647.4M $592.3M $603.7M

As the company reported it, from the “SEGMENT INFORMATION (Details 1)” note of its latest 10-K. Every figure here has been checked against the total revenue the same filing reported. Regions are the filer's own and are not mapped onto a standard list — one company's “Americas” and another's “United States” are different areas, and making them look comparable would mean making at least one of them wrong. Slices under 1% are folded into “Other”.

Annual financial statements

Income statement

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue $6.78B$6.54B$6.83B$9.38B$8.91B$5.76B$6.11B$6.95B$6.27B$5.55B
Cost of revenue $6.28B$5.80B$5.67B$7.19B$6.62B$5.37B$5.44B$5.82B$5.55B$4.94B
Gross profit $501.5M$737.5M$1.17B$2.18B$2.29B$383.4M$670.8M$1.12B$713.5M$606.1M
SG&A $463.3M$408.5M$406.7M$393.9M$416.9M$422.0M$416.9M$430.6M$369.8M$347.2M
Operating income $5.3M$296.5M$712.1M$1.78B$1.85B-$746.7M$177.8M$676.9M$296.6M$107.8M
Interest expense $188.3M$184.5M$181.1M$143.9M$348.0M$292.7M$243.2M$243.2M$217.4M$191.9M
Pre-tax income -$161.1M$141.7M$559.3M$1.68B$1.54B-$1.02B-$36.9M$437.3M$117.2M-$34.2M
Income tax $60.0M$36.7M$107.3M$349.1M$242.0M$50.1M$25.6M$109.4M$432.3M$30.3M
Net income -$101.1M$105.0M$452.0M$1.33B$1.30B-$969.9M-$11.3M$327.9M$549.5M-$3.9M
EPS, basic -0.880.923.669.168.15-6.14-0.071.973.31-0.02
EPS, diluted -0.880.913.578.947.96-6.14-0.071.953.26-0.02
Shares, diluted (wtd. avg.) 114.6M119.5M128.8M148.5M163.0M157.9M162.3M168.4M168.5M165.2M

Balance sheet

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents $167.6M$175.6M$170.3M$194.0M$180.5M$189.7M$220.9M$178.8M$218.4M$184.5M
Short-term investments $0$0$0$0$0$0$0$0$0$0
Receivables ——————$760.4M$776.3M$733.2M$675.0M
Inventory $784.5M$823.5M$858.8M$941.9M$868.3M$674.7M$695.7M$711.4M$682.6M$630.4M
Total current assets $1.97B$2.08B$1.97B$2.16B$2.25B$1.72B$1.71B$1.71B$1.70B$1.55B
Property, plant and equipment $2.20B$2.33B$2.52B$2.67B$2.91B$3.17B$3.32B$3.48B$3.58B$3.70B
Goodwill $1.43B$1.42B$1.42B$1.42B$1.42B$1.42B$2.12B$2.12B$2.12B$2.12B
Other intangibles $174.4M$206.6M$245.8M$273.8M$331.7M$399.4M$448.1M$511.6M$578.5M$629.6M
Total assets $7.33B$7.58B$7.71B$8.04B$8.52B$8.27B$9.19B$9.00B$9.22B$8.76B
Accounts payable $806.1M$861.6M$775.4M$837.7M$847.7M$729.2M$651.9M$636.5M$669.8M$570.8M
Short-term debt $109.7M$129.0M$78.8M$9.7M$201.1M$26.3M$2.1M$125.9M$700.0K$80.5M
Total current liabilities $1.63B$1.63B$1.53B$1.56B$1.68B$1.20B$1.08B$1.12B$954.3M$922.6M
Long-term debt $2.72B$2.71B$2.59B$2.57B$2.58B$3.84B$3.34B$3.10B$3.61B$3.54B
Total liabilities $5.46B$5.52B$5.44B$5.50B$5.87B$6.82B$6.77B$6.17B$6.46B$6.49B
Retained earnings $2.14B$2.36B$2.58B$2.22B$1.01B-$155.1M$941.1M$1.07B$790.3M$373.8M
Total equity $1.84B$2.02B$2.23B$2.54B$2.65B$1.45B$2.42B$2.83B$2.75B$2.27B

Cash flow

Fiscal year FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Operating cash flow $474.2M$503.2M$974.3M$1.92B$1.74B$433.0M$617.3M$907.8M$648.8M$603.2M
Depreciation and amortisation $521.6M$518.1M$533.4M$598.8M$582.5M$568.4M$597.4M$601.4M$558.9M$533.5M
Stock-based compensation $20.7M$17.1M$18.6M$14.1M$8.3M$13.6M$10.7M$12.0M$9.1M$7.5M
Capital expenditure $226.3M$195.1M$236.0M$236.9M$200.6M$298.9M$385.6M$385.2M$294.3M$278.0M
Investing cash flow -$319.6M-$283.7M-$340.8M-$259.7M-$197.4M-$835.7M-$365.6M-$382.3M-$498.5M-$473.5M
Financing cash flow -$163.0M-$212.6M-$656.9M-$1.65B-$1.55B$371.0M-$209.3M-$564.8M-$116.8M-$337.5M
Dividends paid $91.6M$94.2M$101.0M$116.2M$127.8M$126.3M$129.3M$133.6M$133.0M$132.1M
Buybacks $50.5M$300.3M$711.3M$1.35B$251.9M$0$145.9M$50.0M$0$0

Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000074303-26-000027.

Plot the figures US dollars

Income statement Revenue Cost of revenue Gross profit R&D SG&A Total operating expenses Operating income Interest expense Pre-tax income Income tax Net income EPS, basic EPS, diluted Shares, diluted (wtd. avg.)
Balance sheet Cash and equivalents Short-term investments Receivables Inventory Total current assets Property, plant and equipment Goodwill Other intangibles Total assets Accounts payable Short-term debt Total current liabilities Long-term debt Total liabilities Retained earnings Total equity
Cash flow Operating cash flow Depreciation and amortisation Stock-based compensation Capital expenditure Investing cash flow Financing cash flow Dividends paid Buybacks
  • Revenue
  • Gross profit
  • Net income
Revenue, Gross profit, Net income by fiscal year, in US dollars The same figures are in the table below this chart. -5B 0 5B 10B Revenue, FY2016: 5.6B Gross profit, FY2016: 606.1M Net income, FY2016: -3.9M Revenue, FY2017: 6.3B Gross profit, FY2017: 713.5M Net income, FY2017: 549.5M Revenue, FY2018: 6.9B Gross profit, FY2018: 1.1B Net income, FY2018: 327.9M Revenue, FY2019: 6.1B Gross profit, FY2019: 670.8M Net income, FY2019: -11.3M Revenue, FY2020: 5.8B Gross profit, FY2020: 383.4M Net income, FY2020: -969.9M Revenue, FY2021: 8.9B Gross profit, FY2021: 2.3B Net income, FY2021: 1.3B Revenue, FY2022: 9.4B Gross profit, FY2022: 2.2B Net income, FY2022: 1.3B Revenue, FY2023: 6.8B Gross profit, FY2023: 1.2B Net income, FY2023: 452M Revenue, FY2024: 6.5B Gross profit, FY2024: 737.5M Net income, FY2024: 105M Revenue, FY2025: 6.8B Gross profit, FY2025: 501.5M Net income, FY2025: -101.1M FY2016 FY2017 FY2018 FY2019 FY2020 FY2021 FY2022 FY2023 FY2024 FY2025
Fiscal year FY2016FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025
Revenue $5.55B $6.27B $6.95B $6.11B $5.76B $8.91B $9.38B $6.83B $6.54B $6.78B
Gross profit $606.1M $713.5M $1.12B $670.8M $383.4M $2.29B $2.18B $1.17B $737.5M $501.5M
Net income -$3.9M $549.5M $327.9M -$11.3M -$969.9M $1.30B $1.33B $452.0M $105.0M -$101.1M

Recent filings and events

  • Shareholder vote The results of the annual meeting or a special vote. Item 5.07
  • Regulation FD disclosure Something the company told the market and had to tell everyone at once - usually a slide deck or a press release. Item 7.01
  • Other event The catch-all. The company chose to disclose something that fits no other item, so the content is whatever it says it is. Item 8.01
  • Regulation FD disclosure Item 7.01
  • Results announced The quarterly or annual earnings release. Arrives four times a year from almost every company here. Item 2.02
  • Material agreement signed The company entered an agreement outside the ordinary course of business - a large contract, a credit facility, a merger agreement. Item 1.01
  • Regulation FD disclosure Item 7.01
  • Other event Item 8.01
  • Shareholder vote Item 5.07
  • Results announced Item 2.02
  • Officer or director change Someone at the top arrived or left. The item covers everything from a board retirement to a chief executive being removed, and only the filing itself says which. Item 5.02
  • Charter or fiscal year changed A change to the company's governing documents, or to when its year ends. Item 5.03

Item numbers are Form 8-K's own, and a filing date is up to four business days after the thing it reports. The same feed across the whole market.

Others in SIC 2800

TickerCompanyMarket capP/ERevenue growth
SOLS Solstice Advanced Materials Inc. $9.44B 39.9x 3.1%
BCPC BALCHEM CORP $5.64B 37.3x 8.8%
PRM Perimeter Solutions, Inc. $4.55B — 16.4%
IOSP INNOSPEC INC. $2.43B 21.1x -3.7%
NGVT Ingevity Corp $2.39B — -2.7%
CC Chemours Co $1.93B — 0.4%
HUN Huntsman CORP $1.54B — -5.8%
ECVT Ecovyst Inc. $1.07B — 20.9%